Glaxo CEO Replaced 50 Top Managers in Shakeup to Spur Growth
- U.K.’s biggest drugmaker has changed 40% of top 125 staff
- New chief Walmsley is seeking to add new skills, ideas
Photographer: Matthew Lloyd/Bloomberg
This article is for subscribers only.
GlaxoSmithKline Plc’s new chief executive officer, Emma Walmsley, has revamped the top ranks of the U.K.’s largest drugmaker, replacing about 50 of the top 125 managers since taking over last year.
In changing 40 percent of Glaxo’s top executives, Walmsley has hired people from the outside while promoting others from within, the London-based company said Monday by email. She’s seeking to bring new ideas and skills, and to increase diversity to the team, according to the company.